İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
Norwegian Cruise Line Holdings Ltd.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $6.9B | |
|---|---|---|
| Revenue (ttm) | 10.2B | |
| Net income (ttm) | 760.8M | |
| EPS (ttm) | $1.59 | |
| Shares out | 459.2M | |
| P/E (trailing) | 10.2x | |
| P/E (forward) | 8.5x | |
| Volume | 16,399,018 | |
| Beta | 1.96 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $648.0M | $4.84B | $8.55B | $9.48B | $9.83B | +97.3% |
| Gross profit | $-960.1M | $576.7M | $3.08B | $3.79B | $3.14B | — |
| Operating income | $-2.55B | $-1.55B | $930.9M | $1.47B | $1.56B | — |
| Net income | $-4.51B | $-2.27B | $166.2M | $910.3M | $423.2M | — |
| EPS (diluted) | $-12.33 | $-5.41 | $0.39 | $1.89 | $0.92 | — |
| EBITDA | $-1.67B | $-665.1M | $1.77B | $2.49B | $3.82B | — |
| R&D | — | — | — | — | — | — |
| SG&A | $891.5M | $1.38B | $1.34B | $1.43B | $1.55B | +14.8% |
Recent company headlines from major financial publishers.
The base case represents the modal expectation where near-term yield headwinds in Europe are managed through cost discipline ($225M savings), and free cash flow inflects positively as newbuild capex declines. Deleveraging progresses methodically, supporting our Fair Value midpoint of $14.86.
Under favorable macroeconomic conditions, commercial initiatives at Norwegian brand rebuild top-of-funnel bookings, eliminating promotional discounting. Oceania and Regent brands maintain premium pricing power. Accelerated cash flow generation enables rapid debt extinguishment, lowering the equity risk premium and driving the valuation toward the upper band.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 10.6% | $15.7 | $15.9 | $16.1 | $16.3 | $16.5 |
| 11.1% | $15.1 | $15.3 | $15.5 | $15.6 | $15.8 |
| 11.6% | $14.6 | $14.7 | $14.9 | $15.0 | $15.2 |
| 12.1% | $14.1 | $14.2 | $14.3 | $14.5 | $14.6 |
| 12.6% | $13.6 | $13.7 | $13.8 | $14.0 | $14.1 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |